Evidence map›Paper›PMID 39219747›Full record

ReviewClinical epidemiology2024

Epidemiology of Invasive Candidiasis.

Derek J Bays, Emily N Jenkins, Meghan Lyman, Tom Chiller, Nora Strong, Luis Ostrosky-Zeichner, Martin Hoenigl, Peter G Pappas, George R Thompson Iii

Abstract readReview
In one paragraph

Review in Clinical epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Article
  2. Article
  3. RethinkingVaccines · 2026
    Review
  4. Article
  5. Microorganisms · 2026
    Review
  6. Comparative analytical performance of Autof MS2600 and Biotyper Sirius for rapid MALDI-TOF MS identification of microorganisms from positive blood cultures.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Pathogens (Basel, Switzerland) · 2026
    Observational
  12. Emergence and Comparative Analysis ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  13. Article
  14. Article
  15. Global surveillance ofAntimicrobial agents and chemotherapy · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Understanding the Effect of Propolis and Its Derivatives AgainstJournal of fungi (Basel, Switzerland) · 2026
    Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Derek J BaysDepartment of Internal Medicine, Division of Infectious Diseases, School of Medicine, University of California Davis, Sacramento, CA, USA.
Emily N JenkinsASRT, Inc, Atlanta, GA, USA.
Meghan LymanMycotic Disease Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Tom ChillerMycotic Disease Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Nora StrongDivision of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
Luis Ostrosky-ZeichnerDivision of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-4784-7589
Martin HoeniglDivision of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0002-1653-2824
Peter G PappasDivision of Infectious Diseases, Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
George R Thompson IiiDepartment of Internal Medicine, Division of Infectious Diseases, School of Medicine, University of California Davis, Sacramento, CA, USA.ORCID 0000-0001-8518-5750

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Institutional Career Development Core (KL2)KL2TR001859 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HOLMES, JAMES F. · 2016 to 2025
$10.1M
NCATS NIH HHS KL2 TR001859NCATS NIH HHS UL1 TR001860
6 · The paper itself

Abstract

Invasive candidiasis (IC) is an increasingly prevalent, costly, and potentially fatal infection brought on by the opportunistic yeast,

Indexed as

Candidaemergingepidemiologynon-albicans Candida speciesresistance

Identifiers

PMID39219747
PMCPMC11366240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.